RADDISH
Live / Applied — Statement of use — processing complete, to examiner (as of 01 Apr 2026)
What this means for you
Not registered yet, but its 04 Aug 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98116944
- Mark type
- Stylized text
- Filed
- 04 Aug 2023
- Published for opposition
- 20 Aug 2024
- Attorney of record
- Christopher A. Proskey
Goods and services
- Class 035 — Advertising and business services: Promoting public awareness of Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases and issues related thereto in the nature of patient registries, patient research, patient advocacy and patient fundraising efforts; Promoting public awareness of health care issues for patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases, and the importance of patient registration on Alzheimer's, neurodegenerative diseases and other neurological and central nervous system disease registries; Charitable services, namely, organizing and developing programs that aim to improve the lives of patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system disease patients, their caregivers and families; Charitable business services, namely, administration of programs for enabling participants to receive services for Alzheimer's, neurodegenerative diseases and other neurological and central nervous system disease patients, their caregivers and families; Business services, namely, recruitment of participants for neuroscience clinical research; Maintaining a registry of participants for neuroscience clinical research relating to the treatment and prevention of brain disease; Promoting participation in clinical trials and research in the neuroscience field; Recruitment advertising services, namely, advertising clinical trials for the purpose of recruiting patients and placing patients for participation in clinical trials in the neuroscience field
- Class 036 — Insurance and financial services: Charitable fundraising; Charitable fundraising for Alzheimer's disease and neurodegenerative disease research and treatment
- Class 042 — Scientific and technological services: Scientific research in the nature of conducting clinical trials and research for others in the field of Alzheimer's, neuro degenerative diseases and other neurological and central nervous system diseases; Medical and scientific research, namely, conducting clinical trials for others; Medical and scientific research, namely, conducting clinical trials for patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases
- Class 044 — Medical, beauty and agricultural services: Healthcare services; Healthcare services, namely, administering care to patients; Healthcare services, namely, administering care to patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases; Healthcare services, namely, administering tests for patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases; Healthcare services, namely, taking samples from patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases; Establishing tissue, bloods, organ, and stem cell bank of biological samples related to Alzheimer's neurodegenerative diseases and other neurological and central nervous system diseases; Providing health screening services in the field of Alzheimer's, neurodegenerative diseases, and other neurological and central nervous system diseases; Providing health screening services related to Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases
Owner
- Global Alzheimer's Platform Foundation Inc., Washington, DC, US
- Global Alzheimer's Platform Foundation Inc., Washington, DC, US
Prosecution history
- 01 Apr 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Oct 2025 — USE AMENDMENT FILED
- 14 Oct 2025 — TEAS STATEMENT OF USE RECEIVED
- 12 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Apr 2025 — SOU EXTENSION 1 GRANTED
- 11 Apr 2025 — SOU EXTENSION 1 FILED
- 11 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 20 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Aug 2024 — PUBLISHED FOR OPPOSITION
- 31 Jul 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Jul 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Jul 2024 — EXAMINER'S AMENDMENT ENTERED
- 16 Jul 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 16 Jul 2024 — EXAMINERS AMENDMENT E-MAILED